Amgen Inc.
AMGN
$277.29
-$5.35-1.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.01% | 21.51% | 16.68% | 13.11% | 8.50% |
| Total Other Revenue | 9.22% | 15.53% | 10.28% | 5.97% | -15.90% |
| Total Revenue | 18.57% | 21.25% | 16.37% | 12.76% | 7.09% |
| Cost of Revenue | 34.16% | 72.20% | 55.77% | 41.28% | 21.68% |
| Gross Profit | 12.61% | 2.96% | 2.65% | 3.22% | 2.40% |
| SG&A Expenses | 24.67% | 27.90% | 24.43% | 14.66% | 5.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 94.92% | -164.26% | -34.48% | -63.83% | -80.69% |
| Total Operating Expenses | 29.14% | 34.70% | 34.51% | 21.30% | 9.04% |
| Operating Income | -1.28% | -6.59% | -16.13% | -3.45% | 3.63% |
| Income Before Tax | -41.32% | -46.53% | -61.67% | -52.32% | 6.93% |
| Income Tax Expenses | -54.39% | -62.11% | -67.54% | -51.34% | 43.32% |
| Earnings from Continuing Operations | -39.11% | -44.09% | -60.77% | -52.47% | 2.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.11% | -44.09% | -60.77% | -52.47% | 2.52% |
| EBIT | -1.28% | -6.59% | -16.13% | -3.45% | 3.63% |
| EBITDA | 10.37% | 10.19% | -1.11% | 5.14% | 6.66% |
| EPS Basic | -39.39% | -44.30% | -60.83% | -52.50% | 3.15% |
| Normalized Basic EPS | -1.68% | -24.73% | -27.65% | -29.77% | -10.93% |
| EPS Diluted | -39.60% | -44.44% | -60.78% | -52.37% | 3.23% |
| Normalized Diluted EPS | -1.81% | -24.87% | -27.71% | -29.80% | -11.06% |
| Average Basic Shares Outstanding | 0.37% | 0.28% | 0.19% | 0.09% | -0.65% |
| Average Diluted Shares Outstanding | 0.37% | 0.33% | 0.14% | -0.05% | -0.55% |
| Dividend Per Share | 5.63% | 6.60% | 7.62% | 8.68% | 9.79% |
| Payout Ratio | 0.74% | 0.91% | 1.75% | 1.29% | 0.06% |